NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Agency / Source: MD Stem Cells

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Billion Cell Treatments for Eye Disease Increase Stem Cell Effects - MD Stem Cells reports high cell counts for eye stem cell treatments in Florida - MDStemCells.com
Billion Cell Treatments for Eye Disease Increase Stem Cell Effects

 

NewswireTODAY - /newswire/ - Ridgefield, CT, United States, 2013/05/09 - MD Stem Cells reports high cell counts for eye stem cell treatments in Florida - MDStemCells.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bigger is typically better. That is especially true in regenerative medicine where a larger number of stem cells likely provides greater benefit for the patients notes MD Stem Cells.

“We’re pleased to report that we are continuing to see billion plus cell harvests during our bone marrow aspirations. In lab testing following our most recent stem cell treatments in Florida, the cell counts on the delivered stem cell treatments remain far above our expectations” exclaimed Dr. Levy, President of MD Stem Cells. “We continue to have very high total nucleated cell counts following separation using our FDA cleared class 2 device. We attribute these significant counts to our excellent board certified orthopedic surgeon and his superb harvest technique. The more stem cells available, the greater the numbers which are available for treating retina and optic nerve eye problems. When we received the more recent reports back we were extremely pleased. “

Dr. Levy goes on to explain why the numbers are so important and what other factors play a role in clinical improvement for patients. “Patients sometimes see treatments as being equivalent between providers as long as they involve stem cells. This is not necessarily true. MD Stem Cells is associated with Bone Marrow Derived Stem Cells (BMSC) otherwise known as human Mesenchymal Stem Cells. In terms of adult stem cells, Bone Marrow Derived Stem Cells are considered by many researchers to be the closest to the neural or ectodermal derived cells of the retina and optic nerve. Careful harvesting is absolutely critical to obtaining a high stem cell concentration and avoiding dilution with peripheral blood” asserted Dr. Levy.

“The separation technique is also vital to maintain cell viability” Dr. Levy indicated. “Minimal manipulation is used and drugs or chemical substances which might affect the cells are avoided throughout the procedure. The separation is also done directly in the operating room with the patient present so the amount of time the cells are outside the body is at an absolute minimum. The approach has been perfected so as to obtain as pure a nucleated cell fraction as possible”.

“Finally the actual technique of placing the cells is paramount. Our retinal surgeon is an expert at all injections behind, adjacent and inside the eyes. His surgical acumen is exceptional and this is of great advantage for transferring the stem cells gently and into proper position.”

“If you have a higher concentration in the volume of cells provided behind, adjacent and potentially within the eye, there is greater opportunity for tissue uptake of cells and interaction. It may also provide higher levels of certain growth factors that have been shown to be important in stem cell treatments” opined Dr. Levy.

MD Stem Cells and Dr. Levy believe that the increased number of stem cells combined with precise placement may explain the more rapid and vigorous improvements in the eye patients. The total number of photoreceptors in the human eye is estimated to be about 120 million rods which are more sensitive to light and 7 million cones which are sensitive to color. In addition there are an estimated 1.5 million nerve fibers in the optic nerve. The higher number of stem cells may be particularly important for the volume of specialized cells in the target tissues.

MD Stem Cells (mdstemcells.com) is a trusted source of the latest information regarding clinically available adult stem cell treatments, coordinates patient referrals and manages the treatment process for patients and providers. If you or a family member has eye disease or another chronic neurologic or medical condition get the facts about improvements that can be provided by the right team of doctors.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: MD Stem Cells

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Billion Cell Treatments for Eye Disease Increase Stem Cell Effects

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Steven Levy - MDStemCells.com 
203-423-9494 info[.]mdstemcells.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any MD Stem Cells securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From MD Stem Cells / Company Profile


Read Health / Surgery Most Recent Related Newswires:

Philips Receives Frost & Sullivan’s 2025 Global Enabling Technology Leadership Recognition for Excellence in Digital Pathology Healthcare Informatics
S3 Connected Health Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Medical Device Connectivity
Canary Speech Receives Frost & Sullivan’s 2025 North America Technology Innovation Leadership Recognition for Technology Innovation Leadership
Oracle Health Secures TEFCA QHIN Designation, Further Strengthening Interoperability Leadership
Marshall Browning Hospital Selects Oracle Health CommunityWorks to Optimize Care Delivery, Expand Access to Healthcare in its Rural Community
Centre for Addiction and Mental Health is First Hospital in Canada to Select Oracle Health Clinical AI Agent to Streamline Documentation
BASF and Beyond Suncare Welcome WHO Decision to List Broad-spectrum Sunscreen as 'Essential Medicine'
Baraga County Memorial Hospital Selects Oracle Health CommunityWorks to Enhance Clinician and Patient Experience
Oracle and Ci4CC Partner to Accelerate Oncology Innovation
JFCR and NEC Confirm Research Results for Developing Individualized Neoantigen Cancer Vaccines Using Whole-Genome Data
M42 and Oracle Join Forces to Advance Healthy Longevity and Disease Prevention
Oracle and Baylor College of Medicine Collaborate to Advance Research into Alcohol-related Liver Disease
Dräger Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation
Groundbreaking Global Study Underscores Overlooked Health Changes During Menopause
DrFirst Recognized for Enabling Technology Leadership in Healthcare by Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit Enciris Technologies





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)